The name of this superfamily has been modified since the most recent official CATH+ release (v4_3_0). At the point of the last release, this superfamily was named:
"Blc2-like
".
FunFam 3: Bcl-2-like protein 1
Please note: GO annotations are assigned to the full protein sequence rather than individual protein domains. Since a given protein can contain multiple domains, it is possible that some of the annotations below come from additional domains that occur in the same protein, but have been classified elsewhere in CATH.
There are 23 GO terms relating to "molecular function"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Protein binding GO:0005515
Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
|
11 |
P53563 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q07817 (/IPI)
Q64373 (/IPI)
(1 more) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
8 | Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
8 | Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) |
BH3 domain binding GO:0051434
Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.
|
8 | Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) Q07817 (/IPI) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
3 | P53563 (/IPI) Q64373 (/IPI) Q64373 (/IPI) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Protein kinase binding GO:0019901
Interacting selectively and non-covalently with a protein kinase, any enzyme that catalyzes the transfer of a phosphate group, usually from ATP, to a protein substrate.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Clathrin binding GO:0030276
Interacting selectively and non-covalently with a clathrin heavy or light chain, the main components of the coat of coated vesicles and coated pits, and which also occurs in synaptic vesicles.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Identical protein binding GO:0042802
Interacting selectively and non-covalently with an identical protein or proteins.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
2 | P53563 (/IDA) Q90Z98 (/IDA) |
Cysteine-type endopeptidase inhibitor activity involved in apoptotic process GO:0043027
Stops, prevents or reduces the activity of a cysteine-type endopeptidase involved in the apoptotic process.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Protein heterodimerization activity GO:0046982
Interacting selectively and non-covalently with a nonidentical protein to form a heterodimer.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
GTPase binding GO:0051020
Interacting selectively and non-covalently with a GTPase, any enzyme that catalyzes the hydrolysis of GTP.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
BH domain binding GO:0051400
Interacting selectively and non-covalently with the Bcl-2 homology (BH) domain of a protein. Bcl-2-related proteins share homology in one to four conserved regions designated the Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. These domains contribute at multiple levels to the function of these proteins in cell death and survival. Anti-apoptotic members of the Bcl-2 family have four BH domains (BH1-BH4). Pro-apoptotic members have fewer BH domains.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
BH3 domain binding GO:0051434
Interacting selectively and non-covalently with the BH3 domain of a protein of the Bcl-2 family. The BH3 domain is a potent death domain and has an important role in protein-protein interactions and in cell death.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
MDM2/MDM4 family protein binding GO:0097371
Interacting selectively and non-covalently with any isoform of the MDM2/MDM4 protein family, comprising negative regulators of p53.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Transcription factor binding GO:0008134
Interacting selectively and non-covalently with a transcription factor, a protein required to initiate or regulate transcription.
|
1 | P53563 (/IPI) |
Clathrin binding GO:0030276
Interacting selectively and non-covalently with a clathrin heavy or light chain, the main components of the coat of coated vesicles and coated pits, and which also occurs in synaptic vesicles.
|
1 | P53563 (/IPI) |
Protein-containing complex binding GO:0044877
Interacting selectively and non-covalently with a macromolecular complex.
|
1 | P53563 (/IPI) |
GTPase binding GO:0051020
Interacting selectively and non-covalently with a GTPase, any enzyme that catalyzes the hydrolysis of GTP.
|
1 | P53563 (/IPI) |
BH domain binding GO:0051400
Interacting selectively and non-covalently with the Bcl-2 homology (BH) domain of a protein. Bcl-2-related proteins share homology in one to four conserved regions designated the Bcl-2 homology (BH) domains BH1, BH2, BH3 and BH4. These domains contribute at multiple levels to the function of these proteins in cell death and survival. Anti-apoptotic members of the Bcl-2 family have four BH domains (BH1-BH4). Pro-apoptotic members have fewer BH domains.
|
1 | P53563 (/IPI) |
MDM2/MDM4 family protein binding GO:0097371
Interacting selectively and non-covalently with any isoform of the MDM2/MDM4 protein family, comprising negative regulators of p53.
|
1 | P53563 (/IPI) |
There are 117 GO terms relating to "biological process"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
12 |
P53563 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q64373 (/IDA)
(2 more) |
Negative regulation of intrinsic apoptotic signaling pathway GO:2001243
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
9 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q90Z98 (/IDA) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
8 | Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) |
Apoptotic mitochondrial changes GO:0008637
The morphological and physiological alterations undergone by mitochondria during apoptosis.
|
8 | Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) |
Suppression by virus of host apoptotic process GO:0019050
Any viral process that inhibits apoptosis of infected host cells, facilitating prolonged cell survival during viral replication.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Cytokine-mediated signaling pathway GO:0019221
A series of molecular signals initiated by the binding of a cytokine to a receptor on the surface of a cell, and ending with regulation of a downstream cellular process, e.g. transcription.
|
8 | Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) |
Regulation of cytokinesis GO:0032465
Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.
|
8 | Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) Q07817 (/IMP) |
Response to cytokine GO:0034097
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Regulation of mitochondrial membrane permeability GO:0046902
Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Negative regulation of release of cytochrome c from mitochondria GO:0090201
Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
8 | Q07817 (/IC) Q07817 (/IC) Q07817 (/IC) Q07817 (/IC) Q07817 (/IC) Q07817 (/IC) Q07817 (/IC) Q07817 (/IC) |
Negative regulation of execution phase of apoptosis GO:1900118
Any process that stops, prevents or reduces the frequency, rate or extent of execution phase of apoptosis.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage GO:1902230
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236
Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Negative regulation of protein localization to plasma membrane GO:1903077
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Negative regulation of extrinsic apoptotic signaling pathway in absence of ligand GO:2001240
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway in absence of ligand.
|
8 | Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) |
Positive regulation of intrinsic apoptotic signaling pathway GO:2001244
Any process that activates or increases the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
8 | Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
5 | O77737 (/ISS) P53563 (/ISS) Q07816 (/ISS) Q64373 (/ISS) Q64373 (/ISS) |
Regulation of cytokinesis GO:0032465
Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.
|
5 | O77737 (/ISS) P53563 (/ISS) Q07816 (/ISS) Q64373 (/ISS) Q64373 (/ISS) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
4 | P53563 (/IMP) Q64373 (/IMP) Q64373 (/IMP) Q90Z98 (/IMP) |
Negative regulation of execution phase of apoptosis GO:1900118
Any process that stops, prevents or reduces the frequency, rate or extent of execution phase of apoptosis.
|
4 | O77737 (/ISS) P53563 (/ISS) Q64373 (/ISS) Q64373 (/ISS) |
Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236
Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
4 | O77737 (/ISS) P53563 (/ISS) Q64373 (/ISS) Q64373 (/ISS) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
3 | P53563 (/IMP) Q64373 (/IMP) Q64373 (/IMP) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
3 | Q64373 (/IGI) Q64373 (/IGI) Q90Z98 (/IGI) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Ovarian follicle development GO:0001541
The process whose specific outcome is the progression of the ovarian follicle over time, from its formation to the mature structure.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
In utero embryonic development GO:0001701
The process whose specific outcome is the progression of the embryo in the uterus over time, from formation of the zygote in the oviduct, to birth. An example of this process is found in Mus musculus.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Release of cytochrome c from mitochondria GO:0001836
The process that results in the movement of cytochrome c from the mitochondrial intermembrane space into the cytosol, which is part of the apoptotic signaling pathway and leads to caspase activation.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Response to ischemia GO:0002931
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Mitotic cell cycle checkpoint GO:0007093
A cell cycle checkpoint that ensures accurate chromosome replication and segregation by preventing progression through a mitotic cell cycle until conditions are suitable for the cell to proceed to the next stage.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Germ cell development GO:0007281
The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Spermatogenesis GO:0007283
The process of formation of spermatozoa, including spermatocytogenesis and spermiogenesis.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Cell population proliferation GO:0008283
The multiplication or reproduction of cells, resulting in the expansion of a cell population.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Positive regulation of cell population proliferation GO:0008284
Any process that activates or increases the rate or extent of cell proliferation.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Male gonad development GO:0008584
The process whose specific outcome is the progression of the male gonad over time, from its formation to the mature structure.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630
A series of molecular signals in which an intracellular signal is conveyed to trigger the apoptotic death of a cell. The pathway is induced by the detection of DNA damage, and ends when the execution phase of apoptosis is triggered.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Response to radiation GO:0009314
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electromagnetic radiation stimulus. Electromagnetic radiation is a propagating wave in space with electric and magnetic components. These components oscillate at right angles to each other and to the direction of propagation.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Fertilization GO:0009566
The union of gametes of opposite sexes during the process of sexual reproduction to form a zygote. It involves the fusion of the gametic nuclei (karyogamy) and cytoplasm (plasmogamy).
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Response to virus GO:0009615
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Suppression by virus of host apoptotic process GO:0019050
Any viral process that inhibits apoptosis of infected host cells, facilitating prolonged cell survival during viral replication.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Regulation of cytokinesis GO:0032465
Any process that modulates the frequency, rate or extent of the division of the cytoplasm of a cell and its separation into two daughter cells.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Response to cytokine GO:0034097
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytokine stimulus.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Synaptic vesicle recycling via endosome GO:0036466
Synaptic vesicle recycling where vesicles endocytosed via clathrin-coated pits re-acidify and refill with neurotransmitters after passing through an endosomal intermediate.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Regulation of growth GO:0040008
Any process that modulates the frequency, rate or extent of the growth of all or part of an organism so that it occurs at its proper speed, either globally or in a specific part of the organism's development.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of apoptotic process GO:0043066
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Negative regulation of neuron apoptotic process GO:0043524
Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Response to cycloheximide GO:0046898
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cycloheximide stimulus. Cycloheximide (actidione) is an antibiotic produced by some Streptomyces species which interferes with protein synthesis in eukaryotes.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Regulation of mitochondrial membrane permeability GO:0046902
Any process that modulates the frequency, rate or extent of the passage or uptake of molecules by the mitochondrial membrane.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Neuron apoptotic process GO:0051402
Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Neuron apoptotic process GO:0051402
Any apoptotic process in a neuron, the basic cellular unit of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the nervous system.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Regulation of mitochondrial membrane potential GO:0051881
Any process that modulates the establishment or extent of the mitochondrial membrane potential, the electric potential existing across the mitochondrial membrane arising from charges in the membrane itself and from the charges present in the media on either side of the membrane.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Cellular process regulating host cell cycle in response to virus GO:0060154
Any cellular process that modulates the rate or extent of progression through the cell cycle in response to a virus.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Mitochondrion morphogenesis GO:0070584
The process in which the anatomical structures of a mitochondrion are generated and organized.
|
2 | Q64373 (/IGI) Q64373 (/IGI) |
Cellular response to amino acid stimulus GO:0071230
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an amino acid stimulus. An amino acid is a carboxylic acids containing one or more amino groups.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Cellular response to alkaloid GO:0071312
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an alkaloid stimulus. Alkaloids are a large group of nitrogenous substances found in naturally in plants, many of which have extracts that are pharmacologically active.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Cellular response to gamma radiation GO:0071480
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a gamma radiation stimulus. Gamma radiation is a form of electromagnetic radiation (EMR) or light emission of a specific frequency produced from sub-atomic particle interaction, such as electron-positron annihilation and radioactive decay. Gamma rays are generally characterized as EMR having the highest frequency and energy, and also the shortest wavelength, within the electromagnetic radiation spectrum.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Apoptotic process in bone marrow cell GO:0071839
The apoptotic process in cells in the bone marrow.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Negative regulation of release of cytochrome c from mitochondria GO:0090201
Any process that decreases the rate, frequency or extent of release of cytochrome c from mitochondria, the process in which cytochrome c is enabled to move from the mitochondrial intermembrane space into the cytosol, which is an early step in apoptosis and leads to caspase activation.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Extrinsic apoptotic signaling pathway in absence of ligand GO:0097192
A series of molecular signals in which a signal is conveyed from the cell surface to trigger the apoptotic death of a cell. The pathway starts with withdrawal of a ligand from a cell surface receptor, and ends when the execution phase of apoptosis is triggered.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Hepatocyte apoptotic process GO:0097284
Any apoptotic process in a hepatocyte, the main structural component of the liver.
|
2 | Q64373 (/IMP) Q64373 (/IMP) |
Negative regulation of execution phase of apoptosis GO:1900118
Any process that stops, prevents or reduces the frequency, rate or extent of execution phase of apoptosis.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Positive regulation of synaptic vesicle endocytosis GO:1900244
Any process that activates or increases the frequency, rate or extent of synaptic vesicle endocytosis.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Regulation of long-term synaptic depression GO:1900452
Any process that modulates the frequency, rate or extent of long term synaptic depression.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of extrinsic apoptotic signaling pathway via death domain receptors GO:1902042
Any process that stops, prevents or reduces the frequency, rate or extent of extrinsic apoptotic signaling pathway via death domain receptors.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage GO:1902230
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway in response to DNA damage.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway GO:1902236
Any process that stops, prevents or reduces the frequency, rate or extent of an endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of protein localization to plasma membrane GO:1903077
Any process that stops, prevents or reduces the frequency, rate or extent of protein localization to plasma membrane.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Positive regulation of synaptic vesicle exocytosis GO:2000302
Any process that activates or increases the frequency, rate or extent of synaptic vesicle exocytosis.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Positive regulation of synaptic vesicle clustering GO:2000809
Any process that activates or increases the frequency, rate or extent of synaptic vesicle clustering.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of anoikis GO:2000811
Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Positive regulation of ATP biosynthetic process GO:2001171
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Negative regulation of intrinsic apoptotic signaling pathway GO:2001243
Any process that stops, prevents or reduces the frequency, rate or extent of intrinsic apoptotic signaling pathway.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Response to hypoxia GO:0001666
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P53563 (/IEP) |
Tissue homeostasis GO:0001894
A homeostatic process involved in the maintenance of an internal steady state within a defined tissue of an organism, including control of cellular proliferation and death and control of metabolic function.
|
1 | Q90Z98 (/IMP) |
Response to ischemia GO:0002931
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply.
|
1 | P53563 (/IDA) |
Apoptotic process GO:0006915
A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
|
1 | P53563 (/IEP) |
Response to oxidative stress GO:0006979
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of oxidative stress, a state often resulting from exposure to high levels of reactive oxygen species, e.g. superoxide anions, hydrogen peroxide (H2O2), and hydroxyl radicals.
|
1 | P53563 (/IEP) |
Aging GO:0007568
A developmental process that is a deterioration and loss of function over time. Aging includes loss of functions such as resistance to disease, homeostasis, and fertility, as well as wear and tear. Aging includes cellular senescence, but is more inclusive. May precede death and may succeed developmental maturation (GO:0021700).
|
1 | P53563 (/IEP) |
Response to inorganic substance GO:0010035
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an inorganic substance stimulus.
|
1 | P53563 (/IEP) |
Response to organonitrogen compound GO:0010243
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organonitrogen stimulus. An organonitrogen compound is formally a compound containing at least one carbon-nitrogen bond.
|
1 | P53563 (/IEP) |
Response to lead ion GO:0010288
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lead ion stimulus.
|
1 | P53563 (/IEP) |
Response to organic cyclic compound GO:0014070
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organic cyclic compound stimulus.
|
1 | P53563 (/IEP) |
Cerebral cortex development GO:0021987
The progression of the cerebral cortex over time from its initial formation until its mature state. The cerebral cortex is the outer layered region of the telencephalon.
|
1 | P53563 (/IEP) |
Thyroid gland development GO:0030878
The process whose specific outcome is the progression of the thyroid gland over time, from its formation to the mature structure. The thyroid gland is an endoderm-derived gland that produces thyroid hormone.
|
1 | Q90Z98 (/IMP) |
Response to lipopolysaccharide GO:0032496
Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a lipopolysaccharide stimulus; lipopolysaccharide is a major component of the cell wall of gram-negative bacteria.
|
1 | P53563 (/IEP) |
Cellular response to drug GO:0035690
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P53563 (/IEP) |
Response to erythropoietin GO:0036017
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erythropoietin stimulus. Erythropoietin is a glycoprotein hormone that controls erythropoiesis.
|
1 | P53563 (/IEP) |
Cellular response to erythropoietin GO:0036018
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an erythropoietin stimulus.
|
1 | P53563 (/IEP) |
Synaptic vesicle recycling via endosome GO:0036466
Synaptic vesicle recycling where vesicles endocytosed via clathrin-coated pits re-acidify and refill with neurotransmitters after passing through an endosomal intermediate.
|
1 | P53563 (/IMP) |
Response to drug GO:0042493
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a drug stimulus. A drug is a substance used in the diagnosis, treatment or prevention of a disease.
|
1 | P53563 (/IEP) |
Response to hydrogen peroxide GO:0042542
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hydrogen peroxide (H2O2) stimulus.
|
1 | P53563 (/IEP) |
Regulation of apoptotic process GO:0042981
Any process that modulates the occurrence or rate of cell death by apoptotic process.
|
1 | P53563 (/IDA) |
Positive regulation of apoptotic process GO:0043065
Any process that activates or increases the frequency, rate or extent of cell death by apoptotic process.
|
1 | P53563 (/IMP) |
Negative regulation of cysteine-type endopeptidase activity involved in apoptotic process GO:0043154
Any process that stops, prevents, or reduces the frequency, rate or extent of a cysteine-type endopeptidase activity involved in the apoptotic process.
|
1 | Q90Z98 (/IDA) |
Response to peptide hormone GO:0043434
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a peptide hormone stimulus. A peptide hormone is any of a class of peptides that are secreted into the blood stream and have endocrine functions in living animals.
|
1 | P53563 (/IEP) |
Response to electrical stimulus GO:0051602
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an electrical stimulus.
|
1 | P53563 (/IEP) |
Cellular response to cAMP GO:0071320
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cAMP (cyclic AMP, adenosine 3',5'-cyclophosphate) stimulus.
|
1 | P53563 (/IEP) |
Cellular response to interleukin-1 GO:0071347
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an interleukin-1 stimulus.
|
1 | P53563 (/IEP) |
Cellular response to tumor necrosis factor GO:0071356
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a tumor necrosis factor stimulus.
|
1 | P53563 (/IEP) |
Cellular response to hypoxia GO:0071456
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
|
1 | P53563 (/IEP) |
Cellular response to dexamethasone stimulus GO:0071549
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dexamethasone stimulus.
|
1 | P53563 (/IEP) |
Positive regulation of synaptic vesicle endocytosis GO:1900244
Any process that activates or increases the frequency, rate or extent of synaptic vesicle endocytosis.
|
1 | P53563 (/IMP) |
Regulation of long-term synaptic depression GO:1900452
Any process that modulates the frequency, rate or extent of long term synaptic depression.
|
1 | P53563 (/IMP) |
Cellular response to thapsigargin GO:1904579
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a thapsigargin stimulus.
|
1 | P53563 (/IEP) |
Cellular response to astaxanthin GO:1905218
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an astaxanthin stimulus.
|
1 | P53563 (/IEP) |
Cellular response to prolactin GO:1990646
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a prolactin stimulus.
|
1 | P53563 (/IEP) |
Positive regulation of synaptic vesicle exocytosis GO:2000302
Any process that activates or increases the frequency, rate or extent of synaptic vesicle exocytosis.
|
1 | P53563 (/IMP) |
Positive regulation of synaptic vesicle clustering GO:2000809
Any process that activates or increases the frequency, rate or extent of synaptic vesicle clustering.
|
1 | P53563 (/IMP) |
Positive regulation of ATP biosynthetic process GO:2001171
Any process that activates or increases the frequency, rate or extent of ATP biosynthetic process.
|
1 | P53563 (/IMP) |
There are 25 GO terms relating to "cellular component"
The search results have been sorted with the annotations that are found most frequently at the top of the
list. The results can be filtered by typing text into the search box at the top of the table.
GO Term | Annotations | Evidence |
---|---|---|
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
11 |
P53563 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q07817 (/IDA)
Q64373 (/IDA)
(1 more) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
8 | Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
8 | Q07817 (/NAS) Q07817 (/NAS) Q07817 (/NAS) Q07817 (/NAS) Q07817 (/NAS) Q07817 (/NAS) Q07817 (/NAS) Q07817 (/NAS) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
8 | Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) Q07817 (/TAS) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Bcl-2 family protein complex GO:0097136
A protein complex that consists of members of the Bcl-2 family of anti- and proapoptotic regulators. Bcl-2 proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed.
|
8 | Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) Q07817 (/IDA) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
5 | O77737 (/ISS) P53563 (/ISS) Q07816 (/ISS) Q64373 (/ISS) Q64373 (/ISS) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
3 | P53563 (/IDA) Q64373 (/IDA) Q64373 (/IDA) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
3 | P53563 (/IDA) Q64373 (/IDA) Q64373 (/IDA) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | Q64373 (/HDA) Q64373 (/HDA) |
Mitochondrion GO:0005739
A semiautonomous, self replicating organelle that occurs in varying numbers, shapes, and sizes in the cytoplasm of virtually all eukaryotic cells. It is notably the site of tissue respiration.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Mitochondrial envelope GO:0005740
The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Mitochondrial outer membrane GO:0005741
The outer, i.e. cytoplasm-facing, lipid bilayer of the mitochondrial envelope.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Endoplasmic reticulum GO:0005783
The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Centrosome GO:0005813
A structure comprised of a core structure (in most organisms, a pair of centrioles) and peripheral material from which a microtubule-based structure, such as a spindle apparatus, is organized. Centrosomes occur close to the nucleus during interphase in many eukaryotic cells, though in animal cells it changes continually during the cell-division cycle.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Cytosol GO:0005829
The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Membrane GO:0016020
A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Mitochondrial membrane GO:0031966
Either of the lipid bilayers that surround the mitochondrion and form the mitochondrial envelope.
|
2 | Q64373 (/IDA) Q64373 (/IDA) |
Bcl-2 family protein complex GO:0097136
A protein complex that consists of members of the Bcl-2 family of anti- and proapoptotic regulators. Bcl-2 proteins respond to cues from various forms of intracellular stress, such as DNA damage or cytokine deprivation, and interact with opposing family members to determine whether or not the caspase proteolytic cascade should be unleashed.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Presynapse GO:0098793
The part of a synapse that is part of the presynaptic cell.
|
2 | Q64373 (/ISO) Q64373 (/ISO) |
Cytoplasm GO:0005737
All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
|
1 | O77737 (/ISS) |
Mitochondrial envelope GO:0005740
The double lipid bilayer enclosing the mitochondrion and separating its contents from the cell cytoplasm; includes the intermembrane space.
|
1 | P53563 (/IDA) |
Presynapse GO:0098793
The part of a synapse that is part of the presynaptic cell.
|
1 | P53563 (/IDA) |